Navigation path

Community Register of medicinal products

Community register of orphan medicinal products


GRANTED  

Product information

Maribavir

EU orphan designation number: EU/3/07/519   
Active ingredient: Maribavir
Indication: Prevention of cytomegalovirus (CMV) disease in patients with impaired cell mediated immunity deemed at risk
Sponsor: ViroPharma SPRL-BVBA
rue Montoyer 47, 1000 Bruxelles, Belgique / Montoyerstraat 47, 1000 Brussel, België

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/12/2007 Centralised Orphan - Designation EMEA/OD/067/07 (2007)6799 of 18/12/2007
21/07/2008 Other procedure EMEA/OD/067/07
21/07/2008 Other procedure -
24/02/2009 Centralised Orphan - Transfer of orphan designation EMEA/OD/067/07/T/01 (2009)1274 of 20/02/2009
18/12/2009 Other procedure -
17/03/2011 Other procedure -